Pancreatic Enzymes (Pancrelipase) 用于 腹胀与肠胃气胀
A 证据 多项大型临床试验一致显示出显著的益处。外分泌胰腺功能不全的标准治疗方法。胰酶替代疗法（每餐25,000至40,000脂肪酶单位）可使脂肪吸收正常化，有助于消除脂肪泻。属FDA批准药物（Creon、Zenpep）。
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'gutcited.com';
const params = 'ingredient\u003Dpancreatic\u002Denzymes\u0026condition\u003Dbloating\u002Dand\u002Dgas';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
A
结论
外分泌胰腺功能不全的标准治疗方法。胰酶替代疗法（每餐25,000至40,000脂肪酶单位）可使脂肪吸收正常化，有助于消除脂肪泻。属FDA批准药物（Creon、Zenpep）。
Key Study Findings
Randomized Controlled Trial
26 weeks
Open-label
Assessing the impact of an intensive dietitian-led telehealth intervention focusing on nutritional adequacy, symptom control …
Dose: None
vs: Usual nutrition care
Outcome: Quality of life (EORTC-QLQ C30 summary score)
效果: None
None
研究人群: Adults with pancreatic cancer (borderline/locally advanced/metastatic)
Case Reports
n=1
Open-label
Case Report: A case of drug-induced pancreatitis caused by paroxetine with a literature review.
Dose: 20 mg once daily
vs: None
Outcome: Drug-induced pancreatitis
效果: None
None
研究人群: 28-year-old woman with severe depression
Review
Rational Prescribing of Pancreatic Enzymes for Patients with Pancreatic Cancer.
Dose: Pancreatic enzyme replacement therapy (PERT)
vs: None
Outcome: EPI symptom management in pancreatic cancer
效果: None
None
研究人群: Patients with pancreatic cancer and EPI
Case Reports
An Infected Intrahepatic Pancreatic Pseudocyst and Calcified Pancreas: A Rare Complication of Chronic Pancreatitis.
Dose: None
vs: None
Outcome: pain reduction
效果: None
None
研究人群: None
Review
AGA Clinical Practice Update on the Epidemiology, Evaluation, and Management of Exocrine Pancreatic Insufficiency: Expert …
Dose: PERT (pancreatic enzyme replacement)
vs: None
Outcome: EPI diagnosis and treatment guidelines
效果: None
None
研究人群: Patients with exocrine pancreatic insufficiency
Other
n=35
26.0 weeks
Isolated Amylase Deficiency in Children and Its Clinical Implication.
Dose: None
vs: None
Outcome: Diarrhea outcomes
效果: None
None
研究人群: children
Key Statistics
12
研究数量
800
受试者
↑
Positive
A
等级
Referenced Papers
Nutrition journal
2025
Case Report: A case of drug-induced pancreatitis caused by paroxetine with a literature review.
Case Report
Frontiers in medicine
2025
Pharmacy (Basel, Switzerland)
2024
2 次引用
Gastroenterology
2023
87 次引用
Cureus
2023
1 次引用
Journal of pediatric …
2019
14 次引用
Surgery for obesity …
2018
10 次引用
The American journal …
2018
9 次引用
The Medical journal …
2017
59 次引用
The patient
2017
55 次引用
Systematic Review of Exocrine Pancreatic Insufficiency after Gastrectomy for Cancer.
Systematic Review
Digestive surgery
2017
37 次引用
A primer on exocrine pancreatic insufficiency, fat malabsorption, and fatty acid abnormalities.
Review
The American journal …
2017
25 次引用
Revista medica de …
2008
Digestive diseases and …
1999
40 次引用
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
常用剂量
- general:
- 25,000-40,000 lipase units per meal
- epiadults:
- 25,000-50,000 lipase units with meals, 10,000-25,000 with snacks
- epipediatric:
- 500-2,500 lipase units/kg/meal (max 10,000 units/kg/day)
上限： 10,000 lipase units/kg/day (higher doses associated with fibrosing colonopathy)
研究中使用的剂量
| 剂量 | 持续时间 | 效果 | N |
|---|---|---|---|
| None | 26 weeks | Mixed | -- |
| 20 mg once daily | -- | Negative | 1 |
| Pancreatic enzyme replacement therapy (PERT) | -- | Positive | -- |
| None | -- | Mixed | -- |
| PERT (pancreatic enzyme replacement) | -- | Positive | -- |
| None | 26.0 weeks | Mixed | 35 |
| 16 g | 8.7 weeks | Mixed | -- |
| None | 52.0 weeks | Mixed | 20 |
最佳服用时间： With meals and snacks; take half the dose at the beginning and half during the meal
Safety & Side Effects
已报告的副作用
- ⚠ Abdominal pain and cramping
- ⚠ Nausea
- ⚠ Fibrosing colonopathy at very high doses (rare; primarily in cystic fibrosis patients)
- ⚠ Hyperuricemia (high doses of protease can increase uric acid)
已知相互作用
- ● Calcium carbonate and magnesium hydroxide antacids (may reduce enzyme activity)
- ● Acarbose and miglitol (pancreatic amylase may counteract alpha-glucosidase inhibitors)
- ● Iron supplements (protease may reduce iron absorption)
- ● Proton pump inhibitors (may improve enzyme efficacy by reducing acid denaturation)
可耐受最高摄入量： 10,000 lipase units/kg/day (higher doses associated with fibrosing colonopathy)
在开始服用任何补充剂之前，请务必咨询您的医疗保健提供者。
Frequently Asked Questions
Does Pancreatic Enzymes (Pancrelipase) help with 腹胀与肠胃气胀?
Based on 12 studies with 800 participants, there is strong evidence from multiple clinical trials that Pancreatic Enzymes (Pancrelipase) may support 腹胀与肠胃气胀 management. Our evidence grade is A (Strong Evidence).
How much Pancreatic Enzymes (Pancrelipase) should I take for 腹胀与肠胃气胀?
Studies have used various dosages. A commonly studied range is 25,000-40,000 lipase units per meal. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Pancreatic Enzymes (Pancrelipase)?
Reported side effects may include Abdominal pain and cramping, Nausea, Fibrosing colonopathy at very high doses (rare; primarily in cystic fibrosis patients), Hyperuricemia (high doses of protease can increase uric acid). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Pancreatic Enzymes (Pancrelipase) and 腹胀与肠胃气胀?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 12 peer-reviewed studies with 800 total participants. The overall direction of effect is positive.
Related Evidence
References
- [1] Emma McShane et al.. Nutr J. 2025. Assessing the impact of an intensive dietitian-led telehealth intervention focusing on nutritional adequacy, symptom control and optional supplemental jejunal feeding, … doi:10.1186/s12937-025-01113-9 PubMed
- [2] Yangpeng Wu et al.. Front Med (Lausanne). 2025. Case Report: A case of drug-induced pancreatitis caused by paroxetine with a literature review. doi:10.3389/fmed.2025.1688065 PubMed
- [3] Mary Acelle G Garcia et al.. Pharmacy (Basel). 2024. Rational Prescribing of Pancreatic Enzymes for Patients with Pancreatic Cancer. doi:10.3390/pharmacy12020047 PubMed
- [4] David C Whitcomb et al.. Gastroenterology. 2023. AGA Clinical Practice Update on the Epidemiology, Evaluation, and Management of Exocrine Pancreatic Insufficiency: Expert Review. doi:10.1053/j.gastro.2023.07.007 PubMed
- [5] Nabi Nadia et al.. Cureus. 2023. An Infected Intrahepatic Pancreatic Pseudocyst and Calcified Pancreas: A Rare Complication of Chronic Pancreatitis. doi:10.7759/cureus.35384 PubMed
- [6] Puanani Hopson et al.. J Pediatr Gastroenterol Nutr. 2019. Isolated Amylase Deficiency in Children and Its Clinical Implication. doi:10.1097/MPG.0000000000002317 PubMed
- [7] Anabelle Cloutier et al.. Surg Obes Relat Dis. 2018. Long alimentary limb duodenal switch (LADS): a short-term prospective randomized trial. doi:10.1016/j.soard.2017.08.028 PubMed
- [8] Yalda Zolghadri et al.. Am J Pathol. 2018. Malnutrition in Pancreatic Ductal Adenocarcinoma (PDA): Dietary Pancreatic Enzymes Improve Short-Term Health but Stimulate Tumor Growth. doi:10.1016/j.ajpath.2017.11.014 PubMed
- [9] Mehrdad Nikfarjam et al.. Med J Aust. 2017. Diagnosis and management of pancreatic exocrine insufficiency. doi:10.5694/mja16.00851 PubMed
- [10] Colin D Johnson et al.. Patient. 2017. Qualitative Assessment of the Symptoms and Impact of Pancreatic Exocrine Insufficiency (PEI) to Inform the Development of a Patient-Reported Outcome … doi:10.1007/s40271-017-0233-0 PubMed
- [11] Jennifer Straatman et al.. Dig Surg. 2017. Systematic Review of Exocrine Pancreatic Insufficiency after Gastrectomy for Cancer. doi:10.1159/000454958 PubMed
- [12] Samer Alkaade et al.. Am J Manag Care. 2017. A primer on exocrine pancreatic insufficiency, fat malabsorption, and fatty acid abnormalities. PubMed
- [13] Carla Mancilla A et al.. Rev Med Chil. 2008. [Small intestine bacterial overgrowth in patients with chronic pancreatitis]. PubMed
- [14] F Suarez et al.. Dig Dis Sci. 1999. Pancreatic supplements reduce symptomatic response of healthy subjects to a high fat meal. doi:10.1023/a:1026675012864 PubMed
FDA 免责声明: 这些声明未经美国食品药品监督管理局（FDA）评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析，不构成医疗建议。在开始任何补充剂方案之前，请务必咨询您的医疗保健提供者。